Company Profile

Comvita

Comvita is a global natural health company committed to the development of innovative products, backed by ongoing investment in scientific research. Comvita is the world leaders in Manuka (leptospermum) honey and fresh-picked Olive Leaf Extract, which are at the core of the Comvita product range.


Announcements
Title Date Type
Comvita’s resilience despite global supply chain disruption Thu, May 12 2022 09:11 am MKTUPDTE
D&O Ongoing Disclosure Notice Wed, May 04 2022 09:25 am SHINTR
Capital Change Notice - Acquisition of Treasury Stock Tue, Mar 15 2022 01:59 pm SECISSUE
Capital Change Notice - Acquisition of Treasury Stock Wed, Mar 09 2022 08:51 am SECISSUE
Capital Change Notice - Acquisition of Treasury Stock Tue, Mar 08 2022 09:01 am SECISSUE
D&O Ongoing Disclosure Notice Wed, Mar 02 2022 09:45 am SHINTR
Capital Change Notice - Acquisition of Treasury Stock Tue, Mar 01 2022 09:21 am SECISSUE
Record First Half Earnings at Comvita Thu, Feb 24 2022 08:47 am HALFYR
Half year results, updated call details for 24 Feb 2022 Tue, Feb 22 2022 01:11 pm GENERAL
Comvita half year results, call details for 24 Feb 2022 Thu, Feb 10 2022 09:28 am GENERAL
Directors and Executives
David Banfield
Chief Executive Officer and Managing Director
Luke Bunt
Independent Director
Bridget Coates
Independent Director
Nigel Greenwood
Chief Financial Officer
Zhu Guangping
Director
Brett Hewlett
Independent Chairman
Sarah Kennedy
Independent Director
Bob Major
Independent Director
Yawen Wu
Director
Company Details
Registered Office: 23 Wilson Road South, Paengaroa, Bay of Plenty 3189
Postal Address: Private Bag 1, Te Puke 3153
Telephone: +64 7 533 1426
Facsimile: +64 7 533 1118
Website: http://www.comvita.co.nz/
First Listed: 13/11/2003
Balance Date: 30 June
AGM: 20/10/2021
Major Holdings Announcements
Date Name No. Held % Current
29/05/20 Milford Asset Management Limited 4,408,042 - 6.95
03/09/19 Li Wang 8,552,736 16.81 17.21
13/09/17 China Resources Ng Fung Limited 4,582,000 10.12 10.12
Director’s Interests Announcements
Date Name No. Held % Details Other
02/03/22 Brett Hewlett 400,926 - - -
03/12/21 Robert Malcolm Major 32,235 - - -
28/09/21 David Banfield 533,392 - - -
01/09/21 Nigel Greenwood 123,909 - - -
26/06/20 Neil John Craig 1,427,215 - - -
26/06/20 Sarah Jane Kennedy 22,982 - - -
26/06/20 Paul Robert Thomas Reid 59,314 - - -
26/06/20 Luke Bunt 70,000 - - -
21/02/20 Christine Mary Fleury 120,879 - - -
23/10/19 Scott Phillip Coulter 394,294 - - -
06/09/19 Julianne Marie Keast 66,559 - - -
22/06/17 Alan John Bougen 2,009,249 - - -
20/06/17 Sarah Christine Ottrey 36,200 - - -
16/06/17 Murray John Denyer 4,000 - - -
26/05/17 Alan Bougen, Lynda Boug 2,004,249 - - -
07/02/17 Mark Sadd 16,916 - - -
Analysts’ Forecasts
profit2021 profit2022 eps2021 dps2021 sales2021 ebit2021 ebitda2021
mean 14.0 16.7 24.0 2.8 212.8 18.3 28.2
high 14.5 16.7 28.5 5.5 212.8 18.3 29.5
low 13.6 16.7 19.5 .0 212.8 18.3 27.0
sample 2 1 2 2 1 1 2
Disclaimer
Data on this page is from BusinessDesk and NZX Ltd for information purposes only. Details are believed to be accurate but no warranty is given as to accuracy, timeliness, reliability or completeness. No person should rely on the contents of the report and all persons should obtain independent professional advice before acting on any information connected with or contained in this report.
Last Updated: 15/03/2022
Markets market close
Positive earnings lift NZ sharemarket
Dan Brunskill | Fri, 20 May 2022

The NZ market was one of the few climbing markets as investors in other parts of the world worried about the risk of a global recession.

Law & Regulation
Unlawful collection of Companies Office fees fixed under urgency
Ian Llewellyn | Fri, 20 May 2022

The Companies Office's administration of fees may have saved costs, but the problem is it was against the law.

Markets FREE
Brian Gaynor: legacy of a towering financial figure
Brenda Ward | Fri, 20 May 2022

At his funeral in Auckland, family, friends and colleagues of Brian Gaynor recalled a passionate man who had the confidence and courage to back his sometimes controversial opinions.